The global injectable drug delivery market is estimated to be USD 40.5 billion for the year 2016. The market is expected to grow at a CAGR of about 18.1% during the forecasted period and reach USD 92.65 billion by the end of 2021.
Injectable drug delivery technologies allow the transport of drugs formulated in liquid form and facilitate the rapid transport of the drug into the body. It also helps in administering drugs in unconscious and comatose patients. These delivery systems are widely accepted due to their advantage of a faster onset of action with high efficacy. Also, in the recent years, this market has grown due to the increased prevalence of cancer and diabetes.
Global Injectable Drug Delivery Technology Market- Market Dynamics
The report details several driving and restraining factors for the global injectable drug delivery technology market. Some of them are listed below.
The market is segmented on the basis of devices, types, application, and geography. Based on the formulation, the market is segmented into two categories; conventional drug delivery and novel drug delivery. On the basis of devices, the market is segmented into conventional devices and self-injectable devices. The injectable drug delivery devices technologies market is further categorized into conventional injection devices, self-injection devices, and others (microneedles, Nano needles, and blunt needle injections). The market analysis is also provided for different geographical areas, which include North America, Europe, APAC, Middle East & Africa and Latin America.
Some of the key players in the market are:
What the Report Offers